2015. ISPOR Annual International Meeting – Improved Health Status of Haemophilia B Patients Treated with Nonacog Beta Pegol, A New Glycopegylated Recombinant Fix Product with Prolonged Half-Life

Chowdary P, Kearney S, Yee DL, Meunier J, Slothuus U, Hoxer CS. Improved Health Status of Haemophilia B Patients Treated with Nonacog Beta Pegol, A New Glycopegylated Recombinant Fix Product with Prolonged Half-Life. Value Health. 2015 May;18(3):A300. Presented at: ISPOR 20th Annual International Meeting; May 20, 2015; Philadelphia, USA.